The largest database of trusted experimental protocols

Dynabeads

Manufactured by BioLegend
Sourced in United States

Dynabeads are a range of magnetic beads designed for cell separation and purification applications. They are composed of a polymer matrix with embedded magnetic particles, allowing for the isolation and enrichment of specific cell populations or biomolecules from complex biological samples using a magnetic field.

Automatically generated - may contain errors

9 protocols using dynabeads

1

Multiplex Cytokine Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased human IL-1α, IL-1β, IL-6, IL-8, IL-10, IL-12, IL-15, IL-17A, TNF-α, IFN-γ, and MCP-1 capture, and biotinylated detection antibody pairs from BioLegend and IL-2 from Invitrogen™. We purchased the LEGENDplex™ Human Inflammation Panel 1 bead-based immunoassays from BioLegend, We obtained Dynabeads, 2.7 μm-diameter carboxylic acid, and epoxy-linked superparamagnetic beads, avidin-HRP, QuantaRed™ enhanced chemifluorescent HRP substrate, Alexa Fluor™ 488 Hydrazide, EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride), Sulfo-NHS (Sulfo-N-hydroxysulfosuccinimide), MES (2-(N-morpholino)ethanesulfonic acid) buffered saline, bovine serum albumin (BSA), TBS StartingBlock T20 blocking buffer, and PBS SuperBlock blocking buffer from Thermo Fisher Scientific. We obtained Phosphate buffered saline (PBS) from Gibco™, Sylgard™ 184 clear polydimethylsiloxane (PDMS) from Dow Corning, and Fluorocarbon oil (Novec™ 7500) from 3M™.
+ Open protocol
+ Expand
2

Depletion of DPPIV/PLAP-Positive Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dynabeads M-280 Sheep Anti-Mouse IgG (Life Technologies, Paisley, UK) conjugated to anti-DPPIV (anti-CD26) antibody (Biolegend, London, UK) or anti-PLAP antibody were prepared according to the manufacturer’s instructions. Dynabeads coated with anti-IgG1 antibody (Biolegend, London, USA) or anti-IgG2a antibody (Dako, Ely, UK) were used as controls. Briefly, Dynabeads (50 µl) were washed in Ca2+ and Mg2+-free PBS supplemented with 0.1% BSA and 2 mM EDTA at pH 7.4, pelleted with a magnet, and re-suspended in the same buffer. Beads were incubated with 6 µg of either anti-PLAP, anti-DPPIV, anti-IgG1 or anti-IgG2a antibody on a rotating plate overnight, at 4°C. The beads were aggregated using a magnet and supernatants were discarded. MEDIUM/LARGE STB-EVs or SMALL STB-EVs (25 µg for both) were incubated with 10 µl of anti-human Fc receptor blocking reagent for 10 min at 4°C prior to incubation with the beads overnight at 4°C for depletion. Bound and unbound STB-EVs were separated using a magnetic separator (Dynal, Oslo, Norway). Pellets containing bound antigen-positive STB-EVs were immunoblotted. Supernatants (antigen-negative STB-EVs) were analysed by NTA to calculate the percentage of STB-EVs bound to the beads as follows:
%DPPIV or PLAP=TotalDPPIV or PLAP negativeTotal100
+ Open protocol
+ Expand
3

SARS-CoV-2-specific T cell detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were thawed in RPMI 1640 medium (Lonza) supplemented with 10% FBS (Gibco™) and penicillin (100 IU/ml; Gibco™)/streptomycin (100 μg/ml; Gibco™). For T cell stimulation, 0.5×106 PBMCs were cultured in 500μl of medium in a 24-well flat-bottomed microplate and stimulated for 4 days with anti-CD3/anti-CD28 Dynabeads™ Human T-activator (10 μL/mL, Gibco™). For detection of SARS-CoV-2–specific CD4+ and CD8+ T cells, 0.5×106 PBMC cells were stimulated in a 96-well U-bottom plate for 7 days in 200 μl of medium containing 1 μg/ml of PepMix™ SARS-CoV-2 (Spike Glycoprotein) (JPT Peptide Technologies) in the presence of IL-2r (20UI, Biolegend). As a control, some cells were maintained with IL-2r alone. After 6 days, the cells were re-stimulated with 10μg/ml of the aforementioned peptide pools overnight. In order to optimize the detection of intracellular cytokines, Brefeldin A (10 μg/mL; Biolegend) was added in the last 4 h (for Dynabeads™) or 12h (for SARS-CoV-2 peptide pools) of the cell cultures. Cultures were maintained in a humidified incubator with 5% CO2 at 37°C. After stimulation, cells were stained for proliferation and/or phenotypic lymphocyte markers by Flow Cytometry.
+ Open protocol
+ Expand
4

IL-33 Binding Assay with HpARI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein G dynabeads (ThermoFisher Scientific) were coated with 1 μg mouse ST2-Fc (Biolegend), and washed on a DynaMag-2 magnet with PBS 0.02% Tween 20. 100 ng recombinant murine IL-33 (Biolegend) was then mixed with 1 μg HpARI, HpARI_CCP1/2 or HpARI_CCP2/3, and incubated at room temperature for 15 min, prior to adding to ST2-Fc-coated Protein G dynabeads. Beads were washed and bound IL-33 eluted with 50 mM glycine pH2.8, then ran on 4–12% SDS-PAGE gels (ThermoFisher Scientific) under reducing conditions, and transferred to nitrocellulose membranes for western blotting, probing with anti-IL-33 goat polyclonal antibody (R&D Systems AF3626), rabbit anti-goat IgG-HRP secondary antibody (ThermoFisher Scientific) and detected using WesternSure Premium reagent (Licor). Densitometry was carried out using ImageJ, and expressed as fold change from controls at each timepoint.
+ Open protocol
+ Expand
5

In Vitro SUMOylation of Sgo1 and Rts1 Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified Sgo1 (1 µM) was mixed with 5 mM ATP, 15 µM SUMO, 0.5 µM E1 (unless otherwise indicated), 0.5 µM E2 (unless otherwise indicated), and 0.1 µM (unless otherwise indicated) Siz1 (167–508) or Siz2 in a reaction buffer consisting of 25 mM Hepes, pH 7.5, 150 mM KCl, 10 mM MgCl2, 15% glycerol, 0.1% NP-40, 0.1 mM DTT, and 0.25 mM PMSF. The reaction was incubated at 30°C for 2 h (unless otherwise indicated). For detection of SUMOylated Sgo1, the reaction was boiled in SDS sample buffer before analysis by anti-V5 Western blotting.
For Rts1 binding assay, the product of in vitro SUMOylation was incubated with anti-V5 (#MCA1360; Bio-Rad AbD Serotec)–coupled protein G magnetic Dynabeads (Thermo Fisher Scientific) in binding buffer A (25 mM Hepes, pH 7.5, 150 mM KCl, 2 mM MgCl2, 15% glycerol, 0.1% NP-40, 0.1 mM EDTA, 0.5 mM EGTA, and 0.25 mM PMSF) for 2.5 h at 4°C. After washing three times with binding buffer A, beads were incubated with extract from strain AMy8832 for 2 h at 4°C. Beads were washed five times with binding buffer A + 10 mM N-ethylmaleimide and were heated at 65°C for 15 min to elute bound proteins. Sgo1 binding assay was performed similarly, except that Rts1-9Myc was immunoprecipitated from lysate of strain AM8832 by anti-Myc (9E10, #626802; BioLegend)–coupled protein G Dynabeads and subsequently incubated with products of in vitro SUMOylation (with or without ATP).
+ Open protocol
+ Expand
6

Chemotaxis of Activated CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To further confirm the chemotactic effect of CCL5 on CD8+ T cells, naïve CD8+ T cells were purified from mouse spleen and activated with Dynabeads containing mouse T-activator CD3 (Biolegend, Cat# 100301)/CD28 (Biolegend, Cat# 102101) and recombinant mouse IL-2 (Biolegend, Cat# 714604). And then, the activated CD8+ T cells were seeded in the upper chambers of transwell plates (BD Biosciences) and allowed to migrate for 24 h towards the lower chamber containing medium with different concentrations of CCL5 protein (Pepro Tech, Cat# 250-07).
+ Open protocol
+ Expand
7

Restimulation and Flow Cytometry of mT and hT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mT and hT cells were cultured as previously detailed. 5 days post activation with Dynabeads, the cells were restimulated with PMA and ionomycin and blocked with Brefeldin A (Cell Activation Kit with Brefeldin A, Biolegend) for 5 hours according to manufacturer’s instructions. Cells were then washed, stained, and analyzed with flow cytometry.
+ Open protocol
+ Expand
8

Isolation and Activation of Primary T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary mT and hT cells were isolated as previously described and resuspended in T cell culture media without IL-2. Mouse or human αCD3/αCD28 activator Dynabeads (Invitrogen) were added to mT and hT cells, respectively, according to manufacturer recommendations and cells were plated in 96 well plates. After one day of culture, recombinant murine or human IL-2 was added to cultures at a concentration of 50 IU/mL along with any factors being tested. On the seventh day of culture cells were enumerated with cell counting using a hemocytometer and analyzed with flow cytometry. In cultures testing the suppressive effects of DMSO- or βCD-NH2-solubilized Rapa, Rapa was added at concentrations of 10, 100 or 1000 nM and TGF-β1 was used at 5 ng/mL. DMSO concentration was maintained across groups at a concentration of 0.1% (v/v). For CFSE analysis, cells were stained prior to activation with Dynabeads with CFSE (CFSE Cell Division Tracker Kit, Biolegend) according to manufacturer’s instructions. Cells stained with CFSE were analyzed after 72 hours with flow cytometry.
+ Open protocol
+ Expand
9

Activated CD8+ T Cell Migration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD8 + T cells were purified from mouse spleen and activated with Dynabeads containing mouse Tactivator CD3 (Biolegend, Cat# 100301)/CD28 (Biolegend, Cat# 102101) and recombinant mouse IL-2 (Biolegend, Cat# 714604). And then, the activated CD8 + T cells were seeded in the upper chambers of transwell plates (BD Biosciences) and allowed to migrate for 24 h towards the lower chamber containing medium with different concentrations of CCL5 protein (Pepro Tech, Cat# 250-07).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!